Antiplatelet agents and anticoagulants for hypertension (Q24234617)

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

Aspirin, warfarin, or the combination for secondary prevention of coronary events in patients with acute coronary syndromes and prior coronary artery bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

Determination of who may derive most benefit from aspirin in primary prevention: subgroup results from a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

Reduction in the need for hospitalization for recurrent ischemic events and bleeding with clopidogrel instead of aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

Comparison of two aspirin doses on ischemic stroke in post-myocardial infarction patients in the warfarin (Coumadin) Aspirin Reinfarction Study (CARS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

Clinical risk factors for ischemic complications after percutaneous coronary interventions: results from the EPIC trial. The EPIC Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

Diabetes mellitus, glycoprotein IIb/IIIa blockade, and heparin: evidence for a complex interaction in a multicenter trial. EPILOG Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

Secondary stroke prevention with low-dose aspirin, sustained release dipyridamole alone and in combination. ESPS Investigators. European Stroke Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

Ticlopidine lowers plasma fibrinogen in patients with polycythaemia rubra vera and additional thrombotic risk factors. A double-blind controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

Active-control trials: how would a new agent compare with placebo? A method illustrated with clopidogrel, aspirin, and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

The impact of ibuprofen on the efficacy of antihypertensive treatment with hydrochlorothiazide in elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

Comparative safety and tolerability of clopidogrel and aspirin: results from CAPRIE. CAPRIE Steering Committee and Investigators. Clopidogrel versus aspirin in patients at risk of ischaemic events

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

Effect of indomethacin on blood pressure control during treatment with nitrendipine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

Exercise and risk of stroke in male physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

Hemodynamic and humoral effects of low-dose aspirin in treated and untreated essential hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and The International Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

Non-steroidal anti-inflammatory drugs and blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

Effects of non-steroidal anti-inflammatory drugs on prostacyclin and thromboxane biosynthesis in patients with mild essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

Amlodipine and haemodynamic effects of cyclo-oxygenase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

Effect of indomethacin on blood pressure in elderly people with essential hypertension well controlled on amlodipine or enalapril

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

Final report on the aspirin component of the ongoing Physicians' Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

Do trandolapril and indomethacin influence renal function and renal functional reserve in hypertensive patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina. Receptor suppression using integrilin therapy (PURSUIT) trial. The PURSUIT Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

Use of aspirin, epistaxis, and untreated hypertension as risk factors for primary intracerebral hemorrhage in middle-aged and elderly people

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

Incidence of thrombotic occlusion and major adverse cardiac events between two and four weeks after coronary stent placement: analysis of 5,678 patients with a four-week ticlopidine regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

Does chronic aspirin treatment increase blood pressure in man?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

Cyclooxygenase-2--specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

Blood pressure, stroke, and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

Introduction: the quality of the medical evidence: is it good enough?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

Antiplatelet agents for preventing pre-eclampsia and its complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

Long-term treatment with a platelet glycoprotein-receptor antagonist after percutaneous coronary revascularization. EXCITE Trial Investigators. Evaluation of Oral Xemilofiban in Controlling Thrombotic Events

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

The role of rheological and haemostatic factors in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003186.PUB3

Reduction of the antihypertensive effects of enalapril by indomethacin. Its independence from renal sodium retention

21 January 2018

1 reference

12 December 2020

Anticoagulant therapy after acute myocardial infarction. Relation of therapeutic benefit to patient's age, sex, and severity of infarction

1 reference

12 December 2020

No Adverse Effect of Non-Steroidal Anti-Inflammatory Drugs, Sulindac and Diclofenac Sodium, on Blood Pressure Control with a Calcium Antagonist, Nifedipine, in Elderly Hypertensive Patients

1 reference

12 December 2020

Randomized trial of thrombolysis versus heparin in unstable angina

1 reference

12 December 2020

Preventive treatment of cerebral transient ischemia: comparative randomized trial of pentoxifylline versus conventional antiaggregants

1 reference

12 December 2020

Antihypertensive effect of the combination of fosinopril and HCTZ is resistant to interference by nonsteroidal antiinflammatory drugs

1 reference

12 December 2020

Effect of aspirin on mortality in women with symptomatic or silent myocardial ischemia. Israeli BIP Study Group

1 reference

12 December 2020

Enhanced blood pressure response to cyclooxygenase inhibition in salt-sensitive human essential hypertension

1 reference

12 December 2020

Influence of Aspirin Usage on Blood Pressure: Dose and Administration-Time Dependencies

1 reference

12 December 2020

Effects of captopril and ticlopidine, alone or in combination, in hypertensive patients with intermittent claudication

1 reference

12 December 2020

1993 guidelines for the management of mild hypertension: memorandum from a World Health Organization/International Society of Hypertension meeting. Guidelines Sub-Committee

1 reference

12 December 2020

Treatment of hypertension with dihydropyridine calcium antagonists and aspirin

1 reference

12 December 2020

Alcohol consumption and risk of coronary heart disease by diabetes status

1 reference

12 December 2020

Potential mechanisms by which nonsteroidal anti-inflammatory drugs elevate blood pressure: the role of endothelin-1

1 reference

12 December 2020

The influence of ticlopidine on the natural course of retinal vein occlusion

1 reference

12 December 2020

British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary

1 reference

12 December 2020

Effect of ketoprofen on blood pressure, endocrine and renal responses to chronic dosing with captopril in patients with essential hypertension

1 reference

12 December 2020

Abnormalities of rheology and coagulation in hypertension

1 reference

12 December 2020

Efficacy of antiplatelet treatment in hypertensive patients with TIA or stroke

1 reference

12 December 2020

Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study

1 reference

12 December 2020

Effect of low-dose aspirin on thromboxane production and the antihypertensive effect of captopril

1 reference

12 December 2020

Assessment of blood pressure during treatment with naproxen or ibuprofen in hypertensive patients treated with hydrochlorothiazide

1 reference

12 December 2020

Drug-induced inhibition of platelet function delays progression of peripheral occlusive arterial disease. A prospective double-blind arteriographically controlled trial

1 reference

12 December 2020

Effects of Aspirin on Angiotensin-Converting Enzyme Inhibition and Left Ventricular Dilation One Year After Acute Myocardial Infarction

1 reference

12 December 2020

Comparative effects of nabumetone, sulindac, and ibuprofen on renal function.

1 reference

12 December 2020

Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Res

1 reference

12 December 2020

Controlled trial of aspirin in cerebral ischemia: an addendum

1 reference

12 December 2020

Should patients with hypertension receive antithrombotic therapy?

1 reference

12 December 2020

Influence of non-steroidal anti-inflammatory drugs on renal function and 24h ambulatory blood pressure-reducing effects of enalapril and nifedipine gastrointestinal therapeutic system in hypertensive patients

1 reference

12 December 2020

Indomethacin raises blood pressure in untreated essential hypertensives: a double-blind randomly allocated study versus placebo

1 reference

12 December 2020

Endothelial dysfunction in hypertension

1 reference

12 December 2020

Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and TPA for occluded coronary arteries trial

1 reference

12 December 2020

Changes in peripheral hemodynamics and vasodilating prostaglandins after high-dose short-term ibuprofen in chronically treated hypertensive patients

1 reference

12 December 2020

The effects of nonsteroidal anti-inflammatory drugs on blood pressures of patients with hypertension controlled by verapamil

1 reference

12 December 2020

Clopidogrel compatibility with concomitant cardiac co-medications: a study of its interactions with a beta-blocker and a calcium uptake antagonist

1 reference

12 December 2020

Interaction of indomethacin with felodipine and enalapril

1 reference

12 December 2020

Effect of aspirin on blood pressure in hypertensive patients taking enalapril or losartan

1 reference

12 December 2020

Renovascular effects of nonprescription ibuprofen in elderly hypertensive patients with mild renal impairment

1 reference

12 December 2020

1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee

1 reference

12 December 2020

Randomised trial of prophylactic daily aspirin in British male doctors

1 reference

12 December 2020

Antiplatelet therapy is effective in primary prevention of myocardial infarction in patients with a previous cerebrovascular ischemic event

1 reference

12 December 2020

Treatment of poor-prognosis early rheumatoid arthritis: A randomized study of treatment with methotrexate, cyclosporin A, and intraarticular corticosteroids compared with sulfasalazine alone

1 reference

12 December 2020

Different patterns of renal prostaglandins I2 and E2 in patients with essential hypertension with low to normal or high renin activity

1 reference

12 December 2020

A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group

1 reference

12 December 2020

Indomethacin and cyclosporin together produce marked renal vasoconstriction in humans

1 reference

12 December 2020

Does hypertension confer a prothrombotic state? Virchow's triad revisited

1 reference

12 December 2020

Relation of Endothelium, Thrombogenesis, and Hemorheology in Systemic Hypertension to Ethnicity and Left Ventricular Hypertrophy

1 reference

12 December 2020

Haemodynamic changes induced by the correction of anaemia by erythropoietin: role of antiplatelet therapy

1 reference

12 December 2020

Study on the possible interaction between tenoxicam and atenolol in hypertensive patients

1 reference

12 December 2020

Assessment of blood pressure during naproxen therapy in hypertensive patients treated with nicardipine

1 reference

12 December 2020